# A Study to Measure Stomach Emptying in Overweight Non-diabetic and Diabetic Participants Using Tirzepatide

> **NCT04407234** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 36 (actual)

## Conditions studied

- Overweight
- Obesity
- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Tirzepatide
- **DRUG:** Acetaminophen

## Key facts

- **NCT ID:** NCT04407234
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-15
- **Primary completion:** 2021-01-07
- **Final completion:** 2021-01-07
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2024-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04407234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04407234, "A Study to Measure Stomach Emptying in Overweight Non-diabetic and Diabetic Participants Using Tirzepatide". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04407234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*